FDA inspection
McKesson Corporation Headquarters: FDA inspection ending Jul 18, 2018
FDA inspection 1060476 · San Francisco, CA
Key facts
| Inspection ID | 1060476 |
|---|---|
| Firm | McKesson Corporation Headquarters |
| FEI number | 3014548060 |
| Address | 1 Post St |
| City | San Francisco |
| State | CA |
| ZIP | 94104-5203 |
| Fiscal year | 2018 |
| Inspection end date | Jul 18, 2018 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 565854 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data